TheBrief.Health

Six-year ECZTEND data show tralokinumab delivers sustained skin clearance, itch reduction, and consistent safety in atopic dermatitis, supporting long-term IL-13–targeted therapy as a durable management strategy.

ATR inhibitors offer a promising targeted therapy for high-risk hepatoblastoma, exploiting tumor replication stress to improve survival while potentially reducing cisplatin-related toxicity and long-term harm.

Early-life exposure to air pollution and home dampness increases childhood asthma risk, underscoring the need for prevention-focused policies, healthier housing, and environmental screening in pediatric care.

Street psychiatry delivers field-based mental healthcare to unsheltered individuals, addressing complex psychiatric and aging needs while reducing emergency dependence through sustainable funding and integrated, dignity-centered care models.

Comprehensive ADHD management blends medication, behavioral therapy, environmental adjustments, digital tools, and system supports to improve focus, functioning, and long-term outcomes across school, work, and home.

Combat-related PTSD significantly increases fibromyalgia risk, highlighting a bidirectional link between psychological trauma and chronic pain, and underscoring the need for integrated, multidisciplinary veteran care.

Real-world data show biologics effectively improve psoriasis in older adults, though infections, malignancy risk, and adherence barriers require vigilant screening, caregiver support, and multidisciplinary care.

A novel non-surgical contraceptive implant uses injectable self-assembling microcrystals to form a long-acting, retrievable depot, expanding access, enabling self-administration, and reducing procedural barriers worldwide.

A large Swedish study confirms COVID-19 vaccines do not reduce fertility or childbirth rates, providing evidence to counter misinformation and reassure women, clinicians, and policymakers.

GLP-1 medications are transforming diabetes and obesity care, offering significant weight loss and cardiometabolic benefits while raising important considerations around safety, long-term use, cost, and equitable access.

Women with pulmonary embolism are less likely to receive catheter-based thrombectomy than men, highlighting potential care disparities and the need for standardized, equitable treatment pathways.

Emerging research links sex hormones to cardiovascular risk differences in type 2 diabetes, highlighting opportunities for personalized heart disease prevention beyond traditional risk factors.

In emergency medicine, the need for effective pain management is critical, especially for patients in acute distress. Traditionally, intravenous (IV) opioids have been the go-to solution for managing severe pain. However, emerging practices are beginning to shift towards subcutaneous administration, which offers a promising alternative that could change how pain relief is approached in emergency s...

Psoriasis, a chronic skin condition that causes red, itchy, and scaly patches, is often misunderstood and misdiagnosed. Recent discussions among healthcare professionals highlight the importance of accurate diagnosis, as effective treatment depends on properly identifying the condition

Portable MRI technology promises faster, more accessible imaging for multiple sclerosis patients, enabling earlier diagnosis, improved monitoring, reduced healthcare costs, and greater convenience outside traditional hospital settings.

FDA approves pembrolizumab combinations for PD-L1–positive, platinum-resistant ovarian cancer, improving progression-free and overall survival, offering new hope for patients with limited treatment options.

Real-world evidence shows advanced Crohn’s therapies have similar risks for serious infections, VTE, and cardiovascular events, supporting treatment decisions based primarily on effectiveness.

Research shows stroke survivors who suppress emotions face poorer physical and cognitive recovery, highlighting need for routine mental health screening, open communication, and integrated emotional support.

The American Academy of Sleep Medicine released first inpatient obstructive sleep apnea guidelines, promoting hospital screening, continued PAP therapy, specialist consultation, and structured discharge planning.

Financial incentives, including medication discounts, may improve adherence and outcomes for low-income adults with poorly controlled type 2 diabetes, reducing complications and healthcare costs.

New research suggests certain antiplatelet medications may worsen outcomes after brain bleeds, prompting clinicians to reassess prescribing decisions and emergency management strategies.

Rising numbers of elderly Americans with mitral regurgitation are driving personalized treatment strategies, balancing surgery and minimally invasive options to improve outcomes and quality of life.

New Alzheimer’s research identifies molecularly distinct patient subgroups, paving the way for personalized treatments tailored to biological profiles, lifestyles, and individual care needs.

Biological aging metrics may transform steatotic liver disease care, enabling better risk assessment, earlier interventions, and more personalized treatment strategies beyond chronological age alone.

New insights suggest starting hormone therapy after age 65 may raise cancer and heart risks, prompting personalized discussions about timing, benefits, and safer menopause management.